MS Validated Antibodies offers:
Only excellent antibodies validated in more than a thousand tissues
Only one antibody per target, which performs at least as well as its “best in class” competitor
Unique documentation of antibody performance
CPA1 (clone MSVA-601M) is a new marker for immunohistochemistry with very high sensitivity and specificity (>99%) for acinar cell carcinoma of the pancreas. A study on 15,680 tumors of >100 different tumor entities will appear in the next edition of the American Journal of Surgical Pathology.
Acinar cell carcinoma of the pancreas makes up for only 1-2% of pancreatic tumors but is misdiagnosed in a considerable fraction of cases. Based on the data by Uhlig et al, the use of MSVA-601M results in a considerably safer distinction of this tumor entity.
The paper was just published in the American Journal of Surgical Pathology.
